Triple-S Management (GTS) Reaches $29.58 High on May, 8; Shorts at Lannett CO (LCI) Raised By 5.32%

May 8, 2018 - By Vivian Currie

The stock of Triple-S Management Corporation (NYSE:GTS) reached all time high today, May, 8 and still has $30.76 target or 4.00% above today’s $29.58 share price. This indicates more upside for the $690.71 million company. This technical setup was reported by Barchart.com. If the $30.76 PT is reached, the company will be worth $27.63 million more. The stock increased 5.40% or $1.51 during the last trading session, reaching $29.58. About 58,210 shares traded. Triple-S Management Corporation (NYSE:GTS) has risen 52.00% since May 8, 2017 and is uptrending. It has outperformed by 40.45% the S&P500.

Lannett CO Inc (NYSE:LCI) had an increase of 5.32% in short interest. LCI’s SI was 16.12 million shares in May as released by FINRA. Its up 5.32% from 15.31 million shares previously. With 870,300 avg volume, 19 days are for Lannett CO Inc (NYSE:LCI)’s short sellers to cover LCI’s short positions. The SI to Lannett CO Inc’s float is 58.53%. The stock decreased 8.01% or $1.25 during the last trading session, reaching $14.35. About 461,895 shares traded. Lannett Company, Inc. (NYSE:LCI) has declined 34.08% since May 8, 2017 and is downtrending. It has underperformed by 45.63% the S&P500.

Triple-S Management Corporation, through its subsidiaries, provides a portfolio of managed care and related products in the commercial, Medicare, and Medicaid markets in Puerto Rico, the United States. The company has market cap of $690.71 million. The firm operates through three divisions: Managed Care, Life Insurance, and Property and Casualty Insurance. It has a 13.09 P/E ratio. It offers various managed care products, including health maintenance organization plans; preferred well-known provider organization plans; BlueCard program; Medicare Supplement products; Medicare Part D, a prescription drug plan; Medicare Advantage products; Medicaid plans; and claims processing and other administrative services.

Since December 11, 2017, it had 0 insider purchases, and 1 insider sale for $18,557 activity. Shares for $18,557 were sold by Diaz Juan J..

Investors sentiment decreased to 1.33 in Q4 2017. Its down 0.73, from 2.06 in 2017Q3. It fall, as 9 investors sold Triple-S Management Corporation shares while 37 reduced holdings. 17 funds opened positions while 44 raised stakes. 19.93 million shares or 0.51% less from 20.03 million shares in 2017Q3 were reported. Morgan Stanley reported 0% in Triple-S Management Corporation (NYSE:GTS). Amer Century Inc has 41,105 shares for 0% of their portfolio. Cna Corp holds 0.26% in Triple-S Management Corporation (NYSE:GTS) or 44,017 shares. 35,893 are held by Bankshares Of Montreal Can. Macquarie Gp Limited holds 18,357 shares. Panagora Asset Management has invested 0.01% of its portfolio in Triple-S Management Corporation (NYSE:GTS). Parallax Volatility Advisers L P holds 3,570 shares. Citigroup, New York-based fund reported 5,006 shares. Tiaa Cref Invest Mngmt Limited Liability holds 0.01% of its portfolio in Triple-S Management Corporation (NYSE:GTS) for 393,352 shares. Brandywine Mgmt Limited Liability Company accumulated 13,920 shares. Barclays Public Ltd Co stated it has 29,056 shares. State Board Of Administration Of Florida Retirement System reported 0% of its portfolio in Triple-S Management Corporation (NYSE:GTS). Brandes Invest Prns L P owns 0.04% invested in Triple-S Management Corporation (NYSE:GTS) for 79,061 shares. Campbell And Comm Invest Adviser Limited Liability Corp has 0.22% invested in Triple-S Management Corporation (NYSE:GTS) for 11,942 shares. Voya Invest Ltd Liability Corp owns 10,894 shares.

More news for Triple-S Management Corporation (NYSE:GTS) were recently published by: Streetinsider.com, which released: “Triple-S Management (GTS) Tops Q1 EPS by 36c, Beats on Revenues” on May 08, 2018. Prnewswire.com‘s article titled: “Triple-S Management Corporation Reports First Quarter 2018 Results” and published on May 08, 2018 is yet another important article.

More important recent Lannett Company, Inc. (NYSE:LCI) news were published by: Streetinsider.com which released: “Lannett Co (LCI) PT Lowered to $19 at BMO Capital” on May 08, 2018, also Benzinga.com published article titled: “9 Stocks Moving In Monday’s After-Hours Session”, Prnewswire.com published: “Lannett Announces Fiscal 2018 Third-Quarter Financial Results” on May 07, 2018. More interesting news about Lannett Company, Inc. (NYSE:LCI) was released by: Prnewswire.com and their article: “Lannett To Participate At Two Investor Conferences In May” with publication date: May 03, 2018.

Investors sentiment decreased to 1.38 in 2017 Q4. Its down 0.10, from 1.48 in 2017Q3. It is negative, as 17 investors sold Lannett Company, Inc. shares while 44 reduced holdings. 35 funds opened positions while 49 raised stakes. 36.87 million shares or 33.49% more from 27.62 million shares in 2017Q3 were reported. Schwab Charles Invest Management holds 0% in Lannett Company, Inc. (NYSE:LCI) or 166,083 shares. Bridgeway Cap Management holds 0.03% of its portfolio in Lannett Company, Inc. (NYSE:LCI) for 120,000 shares. Dupont Management Corporation accumulated 0.03% or 56,934 shares. Principal Finance Group Inc Inc invested in 225,490 shares. Macquarie owns 60,300 shares or 0% of their US portfolio. 79,808 were reported by Citigroup. Great West Life Assurance Can stated it has 0% in Lannett Company, Inc. (NYSE:LCI). Northern Tru Corporation holds 0% of its portfolio in Lannett Company, Inc. (NYSE:LCI) for 585,534 shares. Arizona State Retirement Sys invested 0.01% of its portfolio in Lannett Company, Inc. (NYSE:LCI). Wells Fargo Mn owns 51,040 shares. Cubist Systematic Strategies Lc reported 14,868 shares. Tiaa Cref Investment Ltd Liability stated it has 0% of its portfolio in Lannett Company, Inc. (NYSE:LCI). Adams Diversified Equity Fund stated it has 30,600 shares. California Pub Employees Retirement System has invested 0% in Lannett Company, Inc. (NYSE:LCI). Clearbridge Investments Ltd Liability Corp reported 1,412 shares.

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company has market cap of $543.06 million. The firm offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. It has a 11.2 P/E ratio. It also provides its products for various medical indications comprising glaucoma, cholesterol, muscle spasm, migraine, pain management, cardiovascular, antipsychosis, gastrointestinal, urinary, bronchospasms, respiratory, gallstone, congestive heart failure, thyroid deficiency, central nervous system, and gout.

Lannett Company, Inc. (NYSE:LCI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts